Molecular Cancer Research · 2018 · 63 citations · 30 references
MedicineGeneticsOncologyCancer GeneticsMolecular OncologyNeoplasiaCancer GenomicsCancer ProgressionMalignant NeoplasmsNext-generation Sequencing In OncologyOncogene MutationsOvarian CancerCancer Mutation AnalysisCopy Number Alteration AnalysisExome Copy Number AnalysisExome SequencingSomatic Mutation AnalysisTargeted Next-generation SequencingTert Promoter MutationsTumor Mutation Analysis
Abstract Adult granulosa cell tumor (aGCT), the most common malignant ovarian sex cord-stromal tumor, is characterized by the forkhead transcription factor FOXL2 p.C134W somatic mutation. Late recurrences are relatively common but the molecular mechanisms of relapse or aggressive behavior are not known. The mutational landscape of FOXL2 p.C134W mutation–positive tumors (n = 22) was determined using whole-exome sequencing (WES). An average of 64 coding and essential splice-site variants were identified per tumor. As the TERT promoter region is poorly covered by the WES, targeted sequencing identified the TERT -124C>T promoter mutation as the only recurrent mutation (∼40% of cases). Pathway analysis suggested an association with DNA replication/repair and the EGFR family canonical pathways. Copy number analysis confirmed that gains of chromosomes 12 and 14 occur in approximately 30% of aGCT and loss of chromosome 22 occurs in approximately 40% of cases. In summary, exome-wide analysis of the mutational landscape of aGCT revealed that, except for the TERT promoter mutation, recurrence and/or aggressive behavior is not defined by activation or loss of specific genes. Implications: This study found that although aGCTs are defined by the presence of a common FOXL2 gene mutation, recurrence and/or aggressive behavior cannot be attributed to subsequent mutation of specific gene(s) or pathways; however, there is a high frequency of the TERT -124C>T promoter mutation, which is associated with more aggressive disease.
30
Mutational landscape and significance across 12 major cancer types
Cyriac Kandoth, Michael D. McLellan, Fabio Vandin et al. · Nature · 2013 · 4.5K citations · Full text
Ahmet Zehir, Ryma Benayed, Ronak Shah et al. · Nature Medicine · 2017 · 3.5K citations
Discovery and saturation analysis of cancer genes across 21 tumour types
Michael S. Lawrence, Petar Stojanov, Craig H. Mermel et al. · Nature · 2014 · 3.2K citations · Full text
Medicine, Bioinformatics, Oncology +16
Landscape of somatic mutations in 560 breast cancer whole-genome sequences
Serena Nik‐Zainal, Helen Davies, Johan Staaf et al. · Nature · 2016 · 2.3K citations · Full text
Life Sciences, Genetics, Oncology +14